fregime
TODAYSTOCKSARCHIVEABOUTGUIDE
Sign inFollow your stocks

Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 10 Oct 2026

ITC, full dossier

GQG Partners sold nearly 36.51 crore ITC shares worth around ₹9,395 crore in a block deal on October 8.

2 publishers have reported this development. Each act of reporting is below, cited.

The record

GQG Partners sold nearly 36.51 crore ITC shares worth around ₹9,395 crore in a block deal on October 8.

indiatimes.com8 Oct 2026

Entities of GQG Partners sold 365 million shares in ITC in a block deal worth ₹9,395.40 crore on the BSE on Thursday.

business-standard.com8 Oct 2026

ITC

₹255.00

▼ -4.03%

Close (EOD), as of 8 Oct 2026 · source

ITC: results, dividends, orders, the full cited record →

More on ITC

The GST Council has approved changes allowing pharmaceutical companies to claim ITC on free samples and medicines destroyed or written off after expiry from FY'28.

9 Oct 2026 · 1 publisher

GQG Partners has scaled back investments worth around ₹24,400 crore across various Indian firms since early 2026.

9 Oct 2026 · 1 publisher

Rajiv Jain-backed GQG sold shares worth Rs 9,395 crore in ITC, reducing its stake after the stock crashed 30% in 2026.

9 Oct 2026 · 1 publisher

The 57th GST Council meeting approved measures to speed up GST refunds, simplify registration and returns, and expand ITC to several business expenses.

8 Oct 2026 · 1 publisher

ITC shares declined more than 3% during intraday trading on Thursday, October 8, following reports of likely block deals.

8 Oct 2026 · 2 publishers

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.